NovaDel Pharma, Inc. (AMEX: NVD), a specialty pharmaceutical company, is focused on developing oral spray formulations of a wide array of marketed therapeutics. NovaMist™, the Company’s proprietary technology, allows drugs to be rapidly delivered directly into the bloodstream, which results in faster onset of action and may provide patient benefits in compliance, convenience and safety. Currently, NovaDel’s most advanced candidates are designed to treat angina, insomnia, and nausea. For further information, visit the Company’s web site at www.novadel.com.
- 17 years ago
QualityStocks
NovaDel Pharma, Inc. (AMEX: NVD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Profit Momentum Builds for Beeline Holdings Inc. (NASDAQ: BLNE) as Next-Gen Platform Accelerates
Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, recently…
-
QualityStocksNewsBreaks – Why SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Is ‘One to Watch’
Disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB:…
-
QualityStocksNewsBreaks – BCII Enterprises Inc. (OTCID: BCII) Details Real-World Applications for Patent-Pending Coupon Token Architecture
BCII Enterprises (OTCID:BCII) today announced real-world applications for its patent-pending Coupon Token architecture, as detailed…